Axsome to Present Findings on Solriamfetol's Cognitive Benefits

Axsome will unveil data demonstrating solriamfetol's ability to enhance cognitive functioning in patients with OSA and narcolepsy.

Related Keywords

Germany ,Herdecke ,Nordrhein Westfalen ,Johannes Gutenberg ,Michael Thorpy ,Solriamfetol Sunosi ,Ulf Kallweit ,Hans Van Dongen ,Samantha Floam ,Washington State University ,Montefiore Medical Center ,Wake Disorders Center ,Department Of Neurology ,Axsome Therapeutics Inc ,Medicine Center ,University Witten Herdecke ,Axsome Therapeutics ,Therapeutics Inc ,Washington State ,Yaroslav Winter ,Mainz Comprehensive Epilepsy ,Sleep Medicine Center ,Johannes Gutenberg University ,Sleep Wake Disorders Center ,Albert Einstein College ,